YD Bio Limited Ordinary Shares
YDESHealthcare|Biotechnology|TW
$5.97
-1.21 (-16.85%)
DCF Value
$0.12
Cash / Share
$0.09
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs
Oct 20, 2026 · GlobeNewsWire
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
Oct 6, 2026 · GlobeNewsWire
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
Aug 31, 2026 · GlobeNewsWire